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Idiopathic Feline Hepatic Lipidosis
B.P. Martz, BS, DVM*
J.W. Tyler, DVM * *
Introduction
Idiopathic hepatic lipidosis (IHL) ofcats is a dis-
ease causing severe liver dysfunction; cats afflicted
with the disease have a guarded to poor prognosis
for recovery. Hepatic lipidosis or fatty liver also oc-
curs in most domestic species including the dog,
the chicken, and ruminants. A variety of etiologies
for hepatic lipidosis are known and may be classi-
fied as either metabolic, nutritional, toxic or hypoxic
conditions. 1,2 The cause of IHL is unknown.
Clinical Findings
The typical signalment of cats diagnosed as hav-
ing II-IL is varied. Early reports suggested older fe-
male cats that were obese or had been obese prior
to illness were more likely to be affected. 3,4 A sub-
sequent report showed IHL to occur in both neu-
tered and intact males and females, thin and obese
animals, and ages ranging from 9 weeks to 8 years
old. 5 Most people believe stressed, anorectic, obese
cats are more commonly afflicted, but not all cats
of that description develop IHL.2,6 Others believe
there is probably no age, sex, breed, nutritional
s~ate, or body condition predilection to IHL. A pos-
s~ble explanation for this is that there are many pos-
SIble causes of fatty liver. It is unlikely that IHL has
the same etiology in all cases.2,6
The history most commonly accompanying cats
with IHL includes a period of profound, total
anorexia following a stressful event. Often times,
vomiting of clear fluid along with infrequent hard
stools or constipation is seen.2,3,5 The cat may also
show lethargy and increased salivation.2,3
Physical exam findings, although inconsistent,
commonly include weight loss with muscle wast-
ing and sparing of body fat stores relative to what
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:,ould be expected with anorexia.2 Icterus in vary-
lng degrees and dehydration are common also.
Hepatomegaly, clinicial evidence of bleeding disor-
ders, and pale mucous membranes are seen in some
cases:2,3 Neurologic deficits are seen frequently in-
cludlng weakness, ataxia, depression, intermittent
blindness, muscle twitching and coma. 3 These cen-
tral nervous system signs may be the result of a
hepatic encephalopathy due to liver dysfunction.
Liver dysfunction in cats with IHL has been shown
by increased serum ammonia levels and abnormal
ammonia tolerance tests.6
Laboratory findings include a nonregenerative,
normocytic, normochromic anemia with hypoplastic
bone marrow. A stress leukogram may also be
seen. 3,6 Liver enzymes SALT (serum alanine
am~notransferase) and SAST (serum aspartate
arnmotransferase) are elevated and in general, corre-
late to the degree of hepatic lipidosis and the
presence of hepatic cellular membrane disruption. 5
Increases in SALT and SAST are not seen in all
cases. 1 SAP (serum alkaline phosphatase) is com-
monly elevated also. Total serum bilirubin is
markedly increased. The ratio of conjugated to un-
c~njugated bilirubin is variable; some authors report
hlgher levels of conjugated bilirubin,2 while others
~eport that unconjugated birirubin predom-
lnates. 3,4,5 Serum triglycerides have been found to
be elevated in those cases in which they were meas-
ured. 5 Other findings that are consistent with liver
f~lure may include hypoalbuminemia, hypoglyce-
mla, decreased BUN, marked bilirubinuria and a
prolonged cloning time.2,3
Post mortem findings may show the liver to be
yellow, friable and enlarged, often with rounded
borders.4,6 There are excessive stores of body fat,
muscle wasting and fat infiltration of the bone mar-
row. 3 Histologic findings of IHL cases have shown
varying degrees of lipid accumulation in hepato-
~ytes. ~owev~r, a distinct fme-vacuolar fatty change
lS conslstent m all cases. 4,6 The liver lobule may be
homogenously involved or affected more in the cen-
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~rolobular or periportal areas. 6 There may be vary-
Ing amounts of centrolobular necrosis, but it is not
always evident. 1,5 Wallerian degeneration may be
seen histologically in the brain which is compati-
ble with hepatic encephalopathy. 3
The diagnosis of IHL is confirmed by a liver bi-
opsy. Routine hematoxylin and eosin staining re-
moves fat from the specimen, but a frozen section
of a formalin-ftxed specimen for fat staining will
confirm the diagnosis. 2
Lipid Metabolism
Fatty acids in the body have two major sources,
namely diet and peripheral fat lipolysis. An
animal's major energy source is from the oxidation
of these fatty acids. When fasting, fatty acids con-
stitute almost the entire source of energy. 7 The
liver's roles in fatty acid metabolism are: 1) oxida-
tion to generate ketone bodies and energy, 2) to
convert excess carbohydrates and amino acids to fat-
ty acids, 3) to release fatty acids from the liver for
deposition in adipose tissue and 4) to esterify free
fatty acids (FFA) which can form phospholipids or
be stored in hepatocytes.
Low levels of insulin associated with low blood
glucose levels increase hormone-sensitive lipase
which increases lipolysis of peripheral fat stores.6
Fatty acid release from adipose tissue is also initiated
by such hormonal releases of ACTH, TSH, GH,
corticosteroids, glucagon, thyroid hormone and the
adrenal hormones epinephrine and norepine-
phrine.6 These hormones elevate hormone-sensitive
lipase in a direct relationship to stimulate lipolysis.
The FFA not oxidized in peripheral tissues are
transported bound to albumin to the liver where
hepatocyte uptake occurs allowing the FFA to be
esterified to triglycerides. Once in the hepatocyte,
triglyceride synthesis is dependent on mitochondrial
fatty acid oxidation, ketone body formation, en-
dogenous fatty acid synthesis and glycerol
precursors.
Very low density lipoproteins (VLDL) are formed
by complexing small lipid acceptor molecules called
apoproteins with triglycerides with the core made
up of triglycerides and a cholesterol ester surrounded
by phospholipid, unesterified cholesterol and pro-
tein. 6,7 The availability of apoprotein B, triglycer-
ide, phospholipid and cholesterol, glycosylation of
apoproteins and transport of the VLDL from sub-
cellular compartments of hepatoytes to tthe
perisinusoidal space of Disse determine the release
of the VLDL into the circulation. 7
The gensity of different lipoproteins depends on
the amount of protein compared to the amount of
triglyceride in them. VLDL are very low in protein
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and high in triglycerides. VLDL are transported to
adipose tissue where, under the influence of
lipoprotein lipase, triglycerides are selectively re-
moved and deposited in peripheral adipose stores.
This causes the density of the remaining product
to increase resulting in a low density lipoprotein.
Pathogenesis of Hepatic Lipidosis
Although there are a variety of causes of hepatic
lipidosis in the domestic species, the reason why
triglycerides accumulate in hepatocytes is the same;
that is, a lipid metabolism defect: the inability of
the liver to form lipoproteins and release them into
the circulation. 1,3,8 The mechanism may involve an
excess supply of FFA being presented to the liver,
a shortage of cofactors, a hepatic structure defect
or a metabolic disorder.
An excess supply of FFA being presented to the
liver may result from increased FFA mobilization
from adipose tissue. Decreased mitochondrial fat-
ty acid oxidation or decreased apoprotein synthesis
result in decreased lipoprotein formation and trans-
port. An imbalance of triglyceride synthesis and
secretion of VLDL follows. Normal hepatocytes can-
not secrete triglycerides as VLDL as quickly as
triglycerides are made from FFA7, thus triglycerides
accumulate in hepatocytes.
Decreased lipoprotein secretion may be the result
of a defect in intracellular transport mechanisms in-
cluding the inhibition of VLDL transport in the en-
doplasmic reticulum, impaired secretory vesicle
formation and migration or impaired exocytoses of
VLDL.
Fatty liver is a common abnormality with and
without concurrent hepatic disease, and· by itself,
a fatty liver has no deleterious effects on hepatic
function. Fatty livers in experimental animals do
not affect hepatic function. Fatty liver associated
with malnutrition likewise, has no deleterious ef-
fect on hepatic function.7 Other evidence shows
normal cats can fast for a considerable length of
time without the severe problems that anorectic cats
which develop IHL have. 3 Not all cats with exces-
sive fat deposits in the liver develop IHL. These facts
lead to speculation that a fatty liver may aggrevate
or expose an underlying metabolic disease in those
animals which develop II-IL.3
Speculated Causes of IIIL
Even though the cause of IHL is unknown, the
knowledge of certain nutritional and metabolic re-
quirements of felines has lead to some speculation.
Cats require 16-19% of their caloric requirements
in protein for maintenance compared to only 4%
for an adult dog. 3,8 They normally have a high rate
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of amino acid catabolism. During a fasting period,
this rapid protein catabolism may result in marked
muscle wasting.
A known nutritional fact of cats is their dietary
need for arginine. Cats are unable to synthesize ar-
ginine and must rely on muscle catabolism for this
essential amino acid during an anorectic period. Ar-
ginine is necessary for the function of urea cycle in
the liver which converts ammonia into urea. An ar-
ginine deficiency can lead to hyperammonemia, a
contributory factor in the development ofhepatoen-
cephalopathy. Arginine deficiency also leads to
decreased ornithine and increased carbamoryl phos-
pate concentrations as alternate metabolic pathways
to the urea cycle are used.2,s Carbamoryl phos-
phate is converted to orotic acid which has been
shown to inhibit the conversion of triglycerides into
lipoproteins resulting in a fatty liver.2,3,S Obese cats
with a slightly fatty liver already would therefore
be more likely affected with a severe fatty accumu-
lation in the liver when an episode of anorexia and
muscle catabolism begins. Protein catabolism may
also result in decreased apoprotein synthesis con-
tributing to triglyceride buildup in the liver.
However, it is not understood why only an occa-
sional anorectic, obese cat is affected with IHL if
this mechanism is the true cause. 2,S
Another possible cause of IHL is the deficiency
of carnitine, a quaternary amine synthesized solely
by the liver. Carnitine and associated acyl transfer-
ase enzymes playa large role in the transportation
of fatty acids into the mitochondria for oxidation
to produce energy (adenosine triphosphate). Car-
nitine deficiency in humans results in lipid accumu-
lation in the liver, heart, muscle and nervous tissue
and may lead to death due to hepatic failure. Car-
nitine deficiency is documented by measuring tis-
sue levels in humans. The condition is treated and
responds with oral camitine supplementation. Simi-
lar studies in cats have not been documented.2,s
Diabetes mellitus is a well known cause of fatty
liver, but it is usually not associated with IHL.6,7
Diabetes mellitus can lead to hepatic failure in cats.2
Some people believe cats with IHL may have an ab-
solute deficiency of insulin similar to that seen in
cats with diabetes mellitus. However, IHL has an
insulin deficiency in the face of normoglycemia or
mild, prolonged hyperglycemia where as cats with
diabetes mellitus have an insulin deficiency with
a marked hyperglycemia.6 A lack of insulin leads
to the breakdown of peripheral fat, decreased clear-
ance of plasma lipids and hepatic lipidosis. Insulin
deficiency may also be the cause for the fasting
hyperglycemia and an abnormal glucose tolerance
tests which are sometimes observed in cats with
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IHL.6 It is also possible the observed abnormalities
in the glucose tolerance tests could be secondary to
hepatic failure instead of an insulin deficiency.6
Peripheral insulin resistance which produces a
relative insulin deficiency may occur in obese cats
as it does in obese humans. 3Elevated serum insu-
lin levels have been shown in cats with a fatty
liver.3,6 These cats also showed a mild fasting
hyperglycemia and abnormal glucose tolerance test
similar to the cats with an absolute insulin deficien-
cy. Hoy/ever, one study showed glucose tolerance
tests in cats (obese and nonobese) with a fatty liver
to have prolonged hyperglycemia with no change
in insulin levels.6This suppons the theory that ab-
solute insulin deficiency rather than insulin
resistance is the cause of the glucose intolerance.6
Ifan absolute insulin deficiency is a cause of IHL,
serum glucagon must also be deficient or the cat
would be diagnosed as having diabetes mellitus.
This would explain the mild hyperglycemia or
hypoglycemia seen in some cats instead of a severe
hyperglycemia. A similar disease in humans involves
a somatostatin secreting tumor, but any relation-
ship to IHL is unknown.6
Another postulated cause of IHL is a toxic hepatic
lipidosis resulting from toxins produced by anaero-
bic bacteria in the intestinal tract that may be ab-
sorbed into the portal circulation and cause necrosis
ofhepatocytes and impairment of lipoprotein secre-
tion. This is seen in man following a jejunal bypass
surgery for obesity where bacteria in the bypassed
intestinal segment proliferate. 2,6 Also bacterial
catabolism of nontoxic bile acids into toxic bile acids
in the colon may result when excessive bile acids
are not absorbed in the ileum. The toxic bile acids
may be absorbed into the portal circulation with
hepatic damage following. 2 Colonic retention of
feces due to constipation may allow absorption of
bacterial or other toxic products also. 5 The fatty liver
resulting from this condition can be prevented and
reversed by treating with metronidazole which con-
trols the bacterial growth.6
There are other toxins known to cause hepatic
lipidosis including alcohol, numerous drugs includ-
ing tetracycline, plant toxins, chemicals and aflatox-
ins.2,6 The severity of the clinical signs associated
with the fatty liver caused by these conditions ap-
parently depends more on the extent ofhepatocel-
lular necrosis than on the presence of fat. Necrosis
and hepatic fat infiltration are separate entities. If
an agent causes lipidosis by a metabolic pathway,
it probably affects adenosine triphosphate concen-
tration in the liver, protein synthesis or lipoprotein
output.7
Protein-calorie malnutrition is a deficiency ofpro-
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tein relative to total calorie intake and has been
shown to cause hepatic lipidosis in man. This may
contribute to the condition in cats because of their
high requirement of protein in their total calories
for maintenance and a high protein catabolism
rate.2,6
Reye's syndrome is a condition of acute hepatic
lipidosis and hepatic encephalopathy in children
usually following a respiratory viral infection, a viral-
drug interaction or other factors. The cause is
unknown, but Reye's syndrome results in hepatic
mitochondrial damage·which prevents oxidation of
fats leading to hepatic lipidosis. Monality is about
20 % • This syndrome has also been postulated as
a cause of IHL.2,4
Other endocrine disorders that can cause hepa-
tic lipidosis include hyperadrenoconicism and
hypothyroidism. Animals affected with the latter
show some of the clinical signs of IHL including
lethargy and anemia. Funher study is indicated.~,5
Starvation causes a release of fatty acids from
adiposse tissue related to lack of blood glucose, sym-
pathetic stimulation and increased growth hormone
release. The resulting increase in serum FFA may
overload the liver's ability to process lipids. 5,7
Tteatment
Recovery rates with today's treatments are only
about 10-20 % •9 If any attempt at treatment of a
cat with IHL is to be successful, early diagnosis and
prompt supponive care is necessary.2Fluid therapy
(50-80 ml/kg/ day) and caloric energy intake
(80-100 kcal/kg/ day) are the most important.8
Fluids can be supplied orally or a balanced electro-
lyte solution can be provided parenterally. Glucose
can be added if the cat is hypoglycemic.2,8,9 Body
weight should be checked daily. 2,8 Caloric intake
is only practically given orally, but the cat with IHL
is usually anorectic, so force feeding or nasogastric,
pharyngostomy or gastrotomy tube feeding may be
needed. 1,2,6,8 Appetite stimulants in the benzodi-
azepam class of drugs (Diazapam, Oxazepam, El-
fazapam, Chlordiazepoxide) are available and can
be tried. Dosages range from 0.2 to,l.O mg/kg as
needed, but generally one to two times per day.
These compounds potentiate gamma-aminobutyric
acid, a neurotransmitter, which inhibits the satiety
center and make the animal feel hungry.2,3,8 In
general, a well balanced canned commercial cat
food blended into a gruel fed 6-8 times per day in
amounts of 5-10 ml/ kg via the tube is sufficient.
The number of feedings can be decreased while the
amount given at one time is gradually increased.
Vitamins should be mixed into the gruel. Fat solu-
ble vitamins can be given parenterally to ensure
Vol. 49, No. 1
their absorption in severe cases.2,8 If the patient is
suffering from a hepatic encephalopathy, a highly
digestible low protein diet should be fed. Milk pro-
teins like cottage cheese are excellent because of
their high digestibility, and they have a high
branched-chain to aromatic amino acid ratio. 5,9
However, an adequate supply of protein for
apoprotein synthesis and arginine for urea cycle
function may be more imponant than restricting
the protein in hepatic encephalopathy cases.6Oral
antibiotics should also be given in cases of hepatic
encephalopathy. 5,9
,Other treatments have been aimed at the insu-
lin deficiency theory with low-doses of insulin given.
Some cats have had a return of appetite and reso-
lution of hepatic lipidosis after weeks to months of
therapy. However, not all cats respond to insulin
therapy and there is risk of hypoglycemia.2,6 If at-
tempted, it should be closely monitored.8
Enemas may be helpful to remove colonic am-
monia and bacterial toxins.6This will prevent fur-
ther ammonia absorption in the colon. As stated
earlier, bacterial toxins may cause hepatic necrosis.
Prolonged retention of colonic contents allows ab-
sorption of bacterial toxins. 5Metronidazole is also
used to control these toxin-producing anaerobic bac-
teria.2 More research is needed on this subject in
cats with IHL.
Some drugs should be avoided when treating
IHL. If antibiotics are used, tetracyclines should be
avoided since it causes inhibition of the release of
lipoproteins in the liver leading to fat deposition. 1
Lipotrophic compounds like choline and methio-
nine mobilize fat from the liver, but their use in
the treatment of IHL is not beneficia1.2,6 They are
only helpful in hepatic lipidosis caused by the
dietary lack of these substances.6,9 Also, excess
methionine can exacerbate hepatic enceph-
alopathy.2,6
G4Icoconicoids should also be avoided because
they enhance protein catabolism and overload the
liver with the end-products.2
Summary
Fatty liver occurs in most domestic species, but
the signs of prolonged anoreXia following stress,
muscle wasting and retention of body fat stores,
'nonregenerative anemia, massive fat infiltration of
the liver, hepatic encephalopathy and liver failure
appear to be a specific syndrome (IHL) suffered by
only cats and more likely obese cats.3However, no
evidence has been documented as to one precise
cause of this syndrome. IHL must be differentiat-
ed from specific disease entities causing similar con-
ditions such as diabetes mellitus, hepatic
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lymphosarcoma, cholangiohepatitis, feline leuke-
mia virus induced hepatitis and others. 3
The unique metabolism of cats has lead to some
insight into the possible causes of n·IL. When these
complicated processes are worked out and fully un-
derstood, a metabolic derangement may be incrimi-
nated as to the cause. A logical and successful
treatment will then follow. 3
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